ORION PHARMA A/S: Financial statements 2014
CVR: 20601116
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ORION PHARMA A/S (CVR 20601116) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 166,850,619 and a net result of DKK 24,675,624 compared with DKK 25,585,348 the year before. That is an increase of 1.3% compared with the year before. The profit margin was 14.8%. Equity in the 2014 report amounted to DKK 46,792,820. The solvency ratio was 61.4%. The company had 31 employees in the financial year.
- Revenue
- DKK 166,850,619
- Gross Profit
- DKK 59,339,762
- Profit/Loss
- DKK 24,675,624
- Equity
- DKK 46,792,820
- Total Assets
- DKK 76,264,070
- Employees
- 31
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 166.9 mio. | 59.3 mio. | 24.7 mio. | 46.8 mio. | 31 |
| 2013 | 164.8 mio. | 64.9 mio. | 25.6 mio. | 39.1 mio. | 33 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ORION PHARMA A/S has published its annual report for 2013. Revenue came to DKK 164,778,384, and the net result was DKK 25,585,348.
About ORION PHARMA A/S
ORION PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1953. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ERCOPHARM A/S. The management consists of Jesper Otto Qvist-Pedersen. The board consists of Satu Maarit Ahomäki (chair), Mikko Tapani Kemppainen and René Kristian Lindell. The company is owned by Orion Corporation. The company has 14 employees (2026). In 2025, the company reported revenue of DKK 329,561,856 and a net result of DKK 10,525,947 compared with DKK 10,899,639 the year before. Equity in the 2025 report amounted to DKK 32,510,625.